Schedule 13G ownership disclosure

CorMedix Inc

Common stock, $0.001 par value · CUSIP: 21900C308

Event date: 2025-11-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 4,955,487.00 · Class: 6.29%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 4,955,487.00 · Class: 6.29%

  • David Kroin

    Shares: 4,955,487.00 · Class: 6.29%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-005229
Form type
SCHEDULE 13G
Filer
CorMedix Inc.
CIK
CIK 1410098
Filed
Dec 01, 2025
Reporting period
Nov 21, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub